Healthcare - Biotechnology - NASDAQ - US
$ 3.54
-3.8 %
$ 8.88 M
Market Cap
-0.55
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--2.37%
EBIT
Estimate
67.76%
Net Income
Estimate
49.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Soligenix, Inc.
SNGX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SNGX
EBIT FORECAST
EBIT Forecast Chart SNGX
NET INCOME FORECAST
Net Income Chart SNGX